Burke Steven Keith's Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Mar 3, 2023
- Accession no.
- 0001562180-23-002199
- Filed
- Mar 3, 2023
- Trade date
- Mar 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $12.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burke Steven KeithCIK 0001619834 | Officer (SVP, Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | SSaleDisposed | −6,613 | $0.88 | −$5,819.44 | 601,564 | Direct | |
| Mar 1, 2023 | Common Stock | SSaleDisposed | −6,400 | $0.88 | −$5,632 | 595,164 | Direct | |
| Mar 1, 2023 | Common Stock | SSaleDisposed | −1,110 | $0.88 | −$976.8 | 594,054 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.